News in the Life Sciences Industry

This material is intended for global medical media only, excl US.

ABBOTT PARK, Ill., June 13, 2020 /PRNewswire/ -- Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading(3) continuous glucose monitoring (CGM) technology, is associated with significant reduction in hemoglobin A1c (HbA1c)... Read more ››

BRUSSELS, June 12, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the first presentations of data from the Phase 3 clinical development program of bimekizumab, its investigational IL-17A and IL-17F inhibitor, as part of a virtual session for the American Academy... Read more ››

ABBOTT PARK, Ill., June 12, 2020 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.

DOWNERS GROVE, Ill., June 10, 2020 /PRNewswire/ -- MAAG Group, part of Read more ››

BAD HOMBURG, Germany, June 10, 2020 /PRNewswire/ -- MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce the establishment of its wholly owned subsidiary MYR... Read more ››

YOKOHAMA, Japan, June 10, 2020 /PRNewswire/ -- TUV Rheinland Japan Ltd. announced that on May 29, 2020 TUV Rheinland LGA Products GmbH issued TUV Rheinland's first MDR certificates under EU Medical Device Regulation 2017/745, for medical devices Terumo Corporation.

Joint Press Release

SINGAPORE, June 9, 2020 /PRNewswire/ -- In response to the physical distancing orders to help reduce the effects of the coronavirus, Oticon has now expanded its eHealth solution so that hearing care professionals can also perform a digital first fit with Oticon RemoteCare for select patients.... Read more ››

Results from prospective trials show a "clear prognostic value" for CTC counts

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

KING OF PRUSSIA, Pa., June 8, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that it has agreed to acquire... Read more ››

ZÜRICH, June 8, 2020 /PRNewswire/ -- EAACI has launched its Guidelines for the use of Biologicals in Patients with Severe Asthma at the EAACI Digital Congress 2020.